First US Patient Gets Experimental Treatment for CCP Virus

First US Patient Gets Experimental Treatment for CCP Virus
Dr. Zhou Min, a recovered COVID-19 patient who exited a 14-day quarantine, donates plasma in the city's blood center in Wuhan in central China's Hubei province on Feb. 18, 2020. Chinatopix via AP, File
Zachary Stieber
Zachary Stieber
Senior Reporter
|Updated:

The first COVID-19 patient in the United States received a transfusion from a recovered patient, a hospital in Texas announced.

Convalescent plasma, one of four components of human blood, is collected from patients who were infected with COVID-19 but later recovered and given to critically ill patients.

Zachary Stieber
Zachary Stieber
Senior Reporter
Zachary Stieber is a senior reporter for The Epoch Times based in Maryland. He covers U.S. and world news. Contact Zachary at [email protected]
twitter
truth
Related Topics